关注
Alejandro Carpy
Alejandro Carpy
Roche Pharma Research and Early Development
在 roche.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Absolute proteome and phosphoproteome dynamics during the cell cycle of Schizosaccharomyces pombe (Fission Yeast)
A Carpy, K Krug, S Graf, A Koch, S Popic, S Hauf, B Macek
Molecular & Cellular Proteomics 13 (8), 1925-1936, 2014
1642014
IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation
TK Oberoi, T Dogan, JC Hocking, RP Scholz, J Mooz, CL Anderson, ...
The EMBO journal 31 (1), 14-28, 2012
1442012
Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells
M Franz-Wachtel, SA Eisler, K Krug, S Wahl, A Carpy, A Nordheim, ...
Molecular & Cellular Proteomics 11 (5), 160-170, 2012
962012
Deep coverage of the Escherichia coli proteome enables the assessment of false discovery rates in simple proteogenomic experiments
K Krug, A Carpy, G Behrends, K Matic, NC Soares, B Macek
Molecular & cellular proteomics 12 (11), 3420-3430, 2013
832013
Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration
H Marei, A Carpy, A Woroniuk, C Vennin, G White, P Timpson, B Macek, ...
Nature communications 7 (1), 10664, 2016
752016
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
C Augsberger, G Hänel, W Xu, V Pulko, LJ Hanisch, A Augustin, J Challier, ...
Blood, The Journal of the American Society of Hematology 138 (25), 2655-2669, 2021
492021
Ubiquitin‐dependent regulation of MEKK 2/3‐MEK 5‐ERK 5 signaling module by XIAP and c IAP 1
AN Takeda, TK Oberoi‐Khanuja, G Glatz, K Schulenburg, RP Scholz, ...
The EMBO journal 33 (16), 1784-1801, 2014
31*2014
Ubiquitin-dependent regulation of Cdc42 by XIAP
A Murali, J Shin, H Yurugi, A Krishnan, M Akutsu, A Carpy, B Macek, ...
Cell death & disease 8 (6), e2900-e2900, 2017
242017
Construction and assessment of individualized proteogenomic databases for large‐scale analysis of nonsynonymous single nucleotide variants
K Krug, S Popic, A Carpy, C Taumer, B Macek
Proteomics 14 (23-24), 2699-2708, 2014
232014
Proteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors
H Marei, A Carpy, B Macek, A Malliri
Cell Cycle 15 (15), 1961-1974, 2016
192016
Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies
KT Kroll, MM Mata, KA Homan, V Micallef, A Carpy, K Hiratsuka, ...
Proceedings of the National Academy of Sciences 120 (35), e2305322120, 2023
142023
Stable isotope labeling by amino acids in cell culture (SILAC) technology in fission yeast
B Maček, A Carpy, A Koch, CC Bicho, WE Borek, S Hauf, KE Sawin
Cold Spring Harbor Protocols 2017 (6), pdb. top079814, 2017
82017
Nic1 inactivation enables stable isotope labeling with 13C615N4-arginine in Schizosaccharomyces pombe
A Carpy, A Patel, YD Tay, IM Hagan, B Macek
Molecular & Cellular Proteomics 14 (1), 243-250, 2015
82015
RG6234: a novel 2: 1 GPRC5D T cell bispecific antibody exhibits best in class potential for the treatment of multiple myeloma as a monotherapy and in combination
J Eckmann, T Fauti, A Zabaleta, L Blanco, S Kassem, N Carrié, S Lorenz, ...
Blood 140 (Supplement 1), 2091-2092, 2022
62022
Targeting Intracellular WT1 in AML utilizing a T cell bispecific antibody construct: augmenting efficacy through combination with lenalidomide
C Klein, C Augsberger, W Xu, C Heitmueller, L Hanisch, J Sam, V Pulko, ...
Blood 134, 4450, 2019
62019
Construction, growth, and harvesting of fission yeast stable isotope labeling by amino acids in cell culture (SILAC) strains
A Koch, CC Bicho, WE Borek, A Carpy, B Maček, S Hauf, KE Sawin
Cold Spring Harbor Protocols 2017 (6), pdb. prot091678, 2017
52017
Stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics and phosphoproteomics in fission yeast
A Carpy, A Koch, CC Bicho, WE Borek, S Hauf, KE Sawin, B Maček
Cold Spring Harbor Protocols 2017 (6), pdb. prot091686, 2017
32017
The physiological interactome of TCR-like antibody therapeutics in human tissues
E Marrer-Berger, A Nicastri, A Augustin, V Kramar, H Liao, LJ Hanisch, ...
Nature Communications 15 (1), 3271, 2024
2024
Targeting of intracellular WT1 with a T-cell bispecific antibody in AML
G Haenel, C Augsberger, W Xu, V Pulko, J Sam, A Ducret, ...
ONCOLOGY RESEARCH AND TREATMENT 44, 31-31, 2021
2021
PF207 TARGETING WILMS TUMOR 1 WITH AT CELL BISPECIFIC ANTIBODY (WT1‐TCB): EX VIVO AND IN VIVO POTENCY BY BIVALENT RECOGNITION OF PEPTIDE‐MHC COMPLEXES FROM AN INTRACELLULAR …
C Augsberger, C Klein, C Heitmüller, W Xu, LJ Hanisch, J Sam, V Pulko, ...
HemaSphere 3, 56, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20